Mr Kaiya of Kyokai Kenpo Optimistic About Reaching 30% Generic Drug Use Target

Shin Kaiya, Executive Director of the Japan Health Insurance Association Speaking at a seminar held by the Japan Society of Generic Medicines’ Subcommittee on Biosimilars on October 16, Shin Kaiya, executive director of the Japan Health Insurance Association (Kyokai Kenpo),...read more